Randall Peyton, MD
Orthopaedic Surgery · Sterling, VANPI 1053392357
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $1,969,581 of the $2,859,732 with a category attached, or 68.9%. Zimmer Biomet accounts for 75.2% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2020 at $1,243,577 and has fallen 98.4% since, to $20,487 in 2025. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 396 payments — averaging $7221.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2.1M
- Anika Therapeutics, Inc.$645K
- Linkbio Corp$46K
- Smith+Nephew$17K
- Nextstep Arthropedix, LLC$558
- Moximed, Inc$503
- plus $1K from 17 others
Across 2 payments — averaging $4733.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amplitude Orthopedics Corporation$9K
What the payments were for
- Royalty or licence$1,969,58169%
- Consulting fees$212,7517%
- Travel & lodging$25,3141%
- Food & beverage$6,8330%
- Ownership interest$570,55620%
- Other$74,6973%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 302 | $2,149,136 |
| Anika Therapeutics, Inc. | 4 | $645,253 |
| Linkbio Corp | 11 | $46,144 |
| Smith+Nephew | 34 | $17,089 |
| Nextstep Arthropedix, LLC | 4 | $558 |
| Moximed, Inc | 5 | $503 |
| Johnson & Johnson(2 entities) | 8 | $188 |
| DJO, LLC | 2 | $138 |
| Shalby Advanced Technologies, Inc. | 1 | $105 |
| Ferring Pharmaceuticals Inc. | 6 | $105 |
| Maxx Orthopedics, Inc. | 1 | $96 |
| Pacira Pharmaceuticals Incorporated | 3 | $68 |
| Fidia Pharma USA Inc. | 4 | $65 |
| Stryker | 1 | $50 |
| Pacira Therapeutics, Inc. | 1 | $47 |
| Molnlycke Health Care US, LLC | 1 | $43 |
| Endo Pharmaceuticals Inc. | 2 | $38 |
| Solventum Corporation | 1 | $23 |
| Medline Industries LP | 1 | $19 |
| Medacta USA, Inc. | 1 | $18 |
| Baudax Bio Inc. | 1 | $18 |
| Davol Inc. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Taperloc$2,012,510
- Arcos$93,067
- G7$39,952
- Avenir$27,073
- Journey II$23,429
- LEGION TKS$5,935
- Taperloc Microplasty$4,800
- Anterior Supine$3,375
- Persona$2,664
- Vanguard$2,516
- Hips-None$2,400
- Persona Revision$1,584
- Legion$1,444
- TMARS Liners$1,250
- Trabecular Metal Shapes$1,250
- iNSitu Hip System$508
- Engage Partial Knee System$474
- MISHA KNEE SYSTEM, SMALL, LEFT$396
- Anthology$325
- NAVIO$230
How this compares
$2,859,732 in reported general payments places this provider in the 95th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 22 | $372 |
| Celecoxib | 27 | $202 |
| Methylprednisolone | 26 | $164 |
| Nabumetone | 16 | $153 |
| Amoxicillin | 43 | $140 |
| Mupirocin | 18 | $127 |
| Meloxicam | 49 | $100 |
| Tramadol Hcl | 21 | $70 |
| Clindamycin Hcl | 15 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Sterling
- Derek OchiaiSterling$272K
- Dale YoungNorth Chesterfield$10.9M
- James DowdVirginia Beach$6.1M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- William MihalkoCharlottesville$2M
- David MillerNorth Chesterfield$1.7M
- Keith LawhornFairfax$1.6M
- Joseph GonduskyVirginia Beach$1.2M
- Joshua HerzogNorth Chesterfield$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.